Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Core Viewpoint - Veracyte, Inc. will present at the 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026, at 9:45 a.m. Pacific Time [1] Group 1: Company Overview - Veracyte is a leading global diagnostics company focused on transforming cancer care for patients worldwide [3] - The company empowers clinicians with high-value insights to guide patients during critical moments in cancer diagnosis and treatment [3] - Veracyte's Diagnostics Platform offers high-performing cancer tests supported by extensive genomic and clinical data, advanced bioinformatics, AI capabilities, and a robust evidence-generation engine [3] Group 2: Presentation Details - Live audio webcasts of the company's presentations will be accessible on Veracyte's website [2] - A replay of the webcast will be available for 30 days after the live broadcast concludes [2]